Literature DB >> 1764965

Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology.

H Maibach1.   

Abstract

Tetracycline and its derivatives are frequently used in the treatment of acne, soft tissue bacterial infections, Lyme disease (borreliosis), chlamydial-infections, and respiratory tract infections. Several pharmacologic and microbiological properties of these antibiotics make them particularly suitable for such uses. First-generation tetracyclines have long been in use; however, the second-generation tetracyclines minocycline, doxycycline hyclate, and doxycycline monohydrate have also become widely prescribed, and can offer advantages to the dermatologist over tetracycline. This paper reviews the important pharmacologic and microbiological characteristics of these three commonly used second-generation tetracyclines, and their clinical applications in dermatology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764965

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  6 in total

Review 1.  A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

Authors:  Abdelwahed Chtarto; Olivier Bockstael; Terence Tshibangu; Olivier Dewitte; Marc Levivier; Liliane Tenenbaum
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

2.  Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.

Authors:  F Breier; G Kunz; H Klade; G Stanek; E Aberer
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

3.  Safety and efficacy of doxycycline in the treatment of rosacea.

Authors:  Sheila Valentín; Adisbeth Morales; Jorge L Sánchez; Abimael Rivera
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-08-12

4.  Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis.

Authors:  Kathrine R Tan; Alan J Magill; Monica E Parise; Paul M Arguin
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

5.  Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.

Authors:  Rebecca Lamb; Marco Fiorillo; Amy Chadwick; Bela Ozsvari; Kimberly J Reeves; Duncan L Smith; Robert B Clarke; Sacha J Howell; Anna Rita Cappello; Ubaldo E Martinez-Outschoorn; Maria Peiris-Pagès; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2015-06-10

Review 6.  Tetracyclines in malaria.

Authors:  Tiphaine Gaillard; Marylin Madamet; Bruno Pradines
Journal:  Malar J       Date:  2015-11-10       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.